(123)I-Meta-iodobenzylguanidine Sympathetic Imaging: Standardization and Application to Neurological Diseases

(123)I-meta-iodobenzylguanidine (MIBG) has become widely applied in Japan since its introduction to clinical cardiology and neurology practice in the 1990s. Neurological studies found decreased cardiac uptake of (123)I-MIBG in Lewy-body diseases including Parkinson's disease and dementia with L...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakajima, Kenichi, Yamada, Masahito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chonnam National University Medical School 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040763/
https://www.ncbi.nlm.nih.gov/pubmed/27689024
http://dx.doi.org/10.4068/cmj.2016.52.3.145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040763/
https://www.ncbi.nlm.nih.gov/pubmed/27689024
http://dx.doi.org/10.4068/cmj.2016.52.3.145

Ejemplares similares